530 J ournal of Medicinal Chemistry, 2001, Vol. 44, No. 4
Dreyer et al.
(5) Weinberg, R. A. The retinoblastoma protein and cell cycle control.
Cell 1995, 81, 323-330.
(6) Kitagawa, M.; Higashi, H.; Suzuki-Takahashi, I.; Segawa, K.;
Hanks, S. K.; Taya, Y.; Nishimura, S.; Okuyama, A. Phospho-
rylation of E2F-1 by cyclin A-cdk2. Oncogene 1995, 10, 229-
236.
(7) Ziebold, U.; Bartsch, O.; Marais, R.; Ferrari, S.; Klempnauer,
K. H. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
Curr. Biol. 1997, 7, 253-260.
(8) De Bondt, H. L.; Rosenblatt, J .; J ancarik, J .; J ones, H. D.;
Morgan, D. O.; Kim, S. H. Crystal structure of cyclin-dependent
kinase 2. Nature 1993, 363, 595-602.
(22) De Azevedo, W. F., J r.; Mueller-Dieckmann, H. J .; Schulze-
Gahmen, U., Worland, P. J .; Sausville, E.; Kim, S. H. Structural
basis for specificity and potency of a flavonoid inhibitor of human
CDK2, a cell cycle kinase. Proc. Natl. Acad. Sci. U.S.A. 1996,
93, 2735-2740.
(23) Conte, L. L.; Chothia, C.; J anin, J . The atomic structure of
protein-protein recognition sites. J . Mol. Biol. 1999, 285, 2177-
2198.
(24) Senderowicz, A. M.; Sausville, E. A. Preclinical and clinical
development of cyclin-dependent kinase modulators. J . Natl.
Cancer Inst. 2000, 92, 376-387.
(9) J effrey, P. D.; Russo, A. A.; Polyak, K.; Gibbs, E.; Hurwitz, J .;
Massague, J .; Pavletich, N. P. Mechanism of CDK activation
revealed by the structure of a cyclinA-CDK2 complex. Nature
1995, 376, 313-320.
(10) Brown, N. R.; Noble, M. E.; Endicott, J . A.; J ohnson, L. N. The
structural basis for specificity of substrate and recruitment
peptides for cyclin-dependent kinases. Nat. Cell Biol. 1999, 1,
438-443.
(11) Harper, J . W.; Elledge, S. J . Cdk inhibitors in development and
cancer. Curr. Opin. Genet. Dev. 1996, 6, 56-64.
(12) Kamb, A.; Gruis, N. A.; Weaver-Feldhaus, J .; Liu, Q.; Harshman,
K.; Tavtigian, S. V.; Stockert, E.; Day, R. S.; J ohnson, B. E.;
Scolnick, M. H. A cell cycle regulator potentially involved in
genesis of many tumor types. Science 1994, 264, 436-440.
(13) Gray, N. S.; Wodicka, L.; Thunnissen, A. M.; Norman, T. C.;
Kwon, S.; Espinoza, F. H.; Morgan, D. O.; Barnes, G.; LeClerc,
S.; Meijer, L.; Kim, S. H.; Lockhart, D. J .; Schultz, P. G.
Exploiting chemical libraries, structure, and genomics in the
search for kinase inhibitors. Science 1998, 281, 533-538.
(14) Kim, S. H.; Schulze-Gahmen, U.; Brandsen, J .; de Azevedo, W.
F., J r. Structural basis for chemical inhibition of CDK2. Prog.
Cell Cycle Res. 1996, 2, 137-145.
(15) Meijer, L.; Kim, S. H. Chemical inhibitors of cyclin-dependent
kinases. Methods Enzymol. 1997, 283, 113-128.
(16) David-Pfeuty, T. Potent inhibitors of cyclin-dependent kinase 2
induce nuclear accumulation of wild-type p53 and nucleolar
fragmentation in human untransformed and tumor-derived cells.
Oncogene 1999, 18, 7409-7422.
(17) Sielecki, T. M.; Boylan, J . F.; Benfield, P. A.; Trainor, G. L.
Cyclin-dependent kinase inhibitors: Useful targets in cell cycle
regulation. J . Med. Chem. 2000, 43, 1-18.
(18) Gray, N., Detivaud, L.; Doerig, C.; Meijer, L. ATP-site directed
inhibitors of cyclin-dependent kinases. Curr. Med. Chem. 1999,
6, 859-875.
(19) De Azevedo, W. F.; Leclerc, S.; Meijer, L.; Havlicek, L.; Strnad,
M.; Kim, S. H. Inhibition of cyclin-dependent kinases by purine
analogues: crystal structure of human cdk2 complexed with
roscovitine. Eur. J . Biochem. 1997, 243, 518-526.
(20) Schulze-Gahmen, U.; Brandsen, J .; J ones, H. D.; Morgan, D. O.;
Meijer, L.; Vesely, J .; Kim, S. H. Multiple modes of ligand
recognition: crystal structures of cyclin-dependent protein ki-
nase 2 in complex with ATP and two inhibitors, olomoucine and
isopentenyladenine. Proteins 1995, 22, 378-391.
(25) Kaelin, W. G., J r.; Pallas, D. C.; DeCaprio, J . A.; Kaye, F. J .;
Livingston, D. M. Identification of cellular proteins that can
interact specifically with the T/E1A-binding region of the ret-
inoblastoma gene product. Cell 1991, 64, 521-532.
(26) Desai, D.; Gu, Y.; Morgan, D. O. Activation of human cyclin-
dependent kinases in vitro. Mol. Biol. Cell 1992, 3, 571-582.
(27) Matsushime, H.; Ewen, M. E.; Strom, D. K.; Kato, J .-Y.; Hanks,
S. K.; Roussel, M. F.; Sherr, C. Identification and properties of
an atypical catalytic subunit (p34PSK-J 3/cdk4) for mammalian
D type G1 cyclins. Cell 1992, 71, 323-334.
(28) Xiong, Y.; Connolly, T.; Futcher, B.; Beach, D. Human D-type
cyclin. Cell 1991, 65, 691-699.
(29) Lee, M. G.; Nurse, P. Complementation used to clone a human
homologue of the fission yeast cell cycle control gene cdc2. Nature
1987, 327, 31-35.
(30) Pines, J .; Hunter, T. Isolation of a human cyclin cDNA: evidence
for cyclin mRNA and protein regulation in the cell cycle and for
interaction with p34cdc2. Cell 1989, 58, 833-846.
(31) Rosenblatt, J .; De Bondt, H.; J ancarik, J .; Morgan, D. O.; Kim,
S. H. Purification and crystallization of human cyclin-dependent
kinase 2. J . Mol. Biol. 1993, 230, 1317-1319.
(32) Otwinowski, Z.; Minor, W. Processing of X-ray diffraction data
collected in oscillation mode. Methods Enzymol. 1997, 276 A,
307-326.
(33) Brunger, A. T. X-PLOR, a system for X-ray crystallography and
NMR; Yale University: New Haven, CT, 1992.
(34) J ones, T. A.; Zou, J . Y.; Cowan, S. W.; Kjeldgaard, M. Improved
methods for building protein models in electron density maps
and the location of errors in these models. Acta Crystallogr. A
1991, 47, 110-119.
(35) Brunger, A. T.; Adams, P. D.; Clore, G. M.; Delano, W. L.; Gros,
P.; Grosse-Kunstleve, R. W.; J iang, J .-S.; Kuszewski, J .; Nilges,
M.; Pannu, N. S.; Read, R. J .; Rice, L. M.; Simonson, T.; Warren,
G. L. Crystallography & NMR system: A new software for
macromolecular structure determination. Acta Crystallogr. D
1998, 54, 905-921.
(36) Collaborative Computational Project Number 4. The CCP4
Suite: Programs for Protein Crystallography. Acta Crystallogr.
D 1994, 50, 760-763.
(21) Schulze-Gahmen, U.; De Bondt, H. L.; Kim, S.-H. High-resolution
crystal structures of human cyclin-dependent kinase 2 with and
without ATP: bound waters and natural ligand as guides for
inhibitor design. J . Med. Chem. 1996, 39, 4540-4546.
(37) Carson, M. Ribbons 2.0. J . Appl. Crystallogr. 1991, 24, 958-961.
J M001043T